Goodman Noah 4
4 · Kymera Therapeutics, Inc. · Filed Apr 9, 2025
Insider Transaction Report
Form 4
Goodman Noah
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-08+100,000→ 100,000 totalExercise: $21.05Exp: 2035-04-07→ Common Stock (100,000 underlying) - Award
Common Stock
2025-04-08+50,000→ 50,081.438 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following April 8, 2025, subject to the reporting person's continued employment through each vesting date.
- [F2]Twenty-five percent (25%) of the shares underlying this stock option shall vest on April 8, 2026, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date.